UCLA Hematology/Oncology - Encino — Encino, California

UCLA Hematology/Oncology - Encino is a clinical research site located in Encino, California, United States 91436.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology - Encino has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Urothelial Carcinoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC).

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology - Encino?

UCLA Hematology/Oncology - Encino has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology - Encino conducted?

UCLA Hematology/Oncology - Encino has 3 clinical trials on record, with 3 currently active. Their work covers HER2-positive Breast Cancer, Urothelial Carcinoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC).

Is UCLA Hematology/Oncology - Encino accredited by Crixeo Health?

UCLA Hematology/Oncology - Encino has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology - Encino?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.